Vimarsana
Biggest News Aggregation in the World

Page 5 - 2 Dg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from 2 Dg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In 2 Dg Today - Breaking & Trending Today

Govt. releases DRDO's COVID drug for emergency use - Vimarsana News

Govt. releases DRDO's COVID drug for emergency use

Updated: Developed with DRL, it reduces oxygen-dependence in patients Share Article AAA Defence Minister Rajnath Singh hands over the first batch of 2-DG anti Covid drug to the Union Health Minister Harsh Vardhan, in New Delhi on May 17, 2021. Photo: Twitter/@rajnathsingh   Developed with DRL, it reduces oxygen-dependence in patients The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) — developed by the Defence Research and Development Organisation (DRDO) along with Dr Reddy’s Laboratories (DRL), Hyderabad — was on Monday released for emergency use. Defence M...

DRDO's Covid Drug 2-DG: 10,000 Packets Of DRDO's Anti-Covid Oral Drug To Be Distributed Tomorrow - Vimarsana News

DRDO's Covid Drug 2-DG: 10,000 Packets Of DRDO's Anti-Covid Oral Drug To Be Distributed Tomorrow

COVID-19: The 2-G drug had shown promising results in its phase 2 and phase 3 clinical trials. New Delhi: An anti-coronavirus drug developed by Defence Research and Development Organisation (DRDO) will be launched tomorrow, with Union Defence Minister Rajnath Singh distributing around 10,000 doses to some hospitals in the national capital. The drug, called 2-deoxy-D-glucose or 2-DG, was developed by a DRDO lab in collaboration with the Hyderabad-based pharma giant, Dr Reddy's Laboratories. The Drugs Controller General of India (DCGI), the country's top drug regulator, has approved the medici...

Source: ndtv.com
What is 2-DG: Crucial Information Missing About DRDO's Anti-COVID Drug Approved for Emergency Use - Vimarsana News

What is 2-DG: Crucial Information Missing About DRDO's Anti-COVID Drug Approved for Emergency Use

2-DG 's therapeutic use for COVID-19 is set to begin in the coming week. However, there are several gaps in the information surrounding the drug trials and a lack of available data.

Dr Reddy's Q4 net down 28% at ₹554 cr - The Hindu BusinessLine - Vimarsana News

Dr Reddy's Q4 net down 28% at ₹554 cr - The Hindu BusinessLine

Pharma major Dr Reddy’s Laboratories Ltd net profit decreased 28 per cent at ₹554 crore in the fourth quarter ended March 31, 2021 as against ₹764 crore in the corresponding quarter of the previous

Top news of the day: Government says COVID-19 positive test not mandatory for hospital admission; DRDO-developed anti-COVID drug approved for emergency use, and more - Vimarsana News

Top news of the day: Government says COVID-19 positive test not mandatory for hospital admission; DRDO-developed anti-COVID drug approved for emergency use, and more

The Drugs Controller General of India (DCGI) has granted permission for emergency use of anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL), Hyderabad. In his virtual address at the 25th meeting of the Group of Ministers, the Health Minister said, “180 districts have showed no fresh cases in the last seven days, 18 districts in 14 days, 54 districts in 21 days and 32 districts wer...